Ligand Enters OmniAb License Agreement with TeneoBio, Inc.
Ligand Pharmaceuticals has entered into a worldwide license agreement with Menlo Park, CA-based TeneoBio.
Under the license, TeneoBio will be able to use the OmniFlic technology from…
Read More...
Read More...